Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Weill Cornell Medicine Multiple Sclerosis Center
Explore this Website
Home
Patient Care
Toggle Patient Care menu options
Conditions We Treat
Toggle Conditions We Treat menu options
Multiple Sclerosis
Clinically Isolated Syndrome
Neuromyelitis Optica
Optic Neuritis
Transverse Myelitis
Treatments Available
Toggle Treatments Available menu options
Multiple Sclerosis Rehabilitation
What Our Patients Are Saying
Request an Appointment
Referring Physicians
Comprehensive Care
Helpful Links & Resources
Our Physicians
Research
Toggle Research menu options
The Myelin Regeneration Project
Imaging Research - MRI & PET
Clinical Research
Publications
News & Updates
Toggle News & Updates menu options
Events Calendar
Contact Us
About Us
Wellness Seminar Series
Weill Cornell Medicine
Care
Discover
Teach
Home
Patient Care
Research
News & Updates
Contact Us
About Us
Wellness Seminar Series
Home
Publications
Found 9 results
Author
[
Title
]
Type
Year
Filters:
Filter
is
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Kaunzner UW
,
Salamon E
,
Pentsova E
,
Rosenblum M
,
Karimi S
,
Nealon N
,
Lavi E
,
Jamieson DG
. 2017.
An Acute Disseminated Encephalomyelitis-Like Illness in the Elderly: Neuroimaging and Neuropathology Findings.
.
J Neuroimaging. 27(3):306-311.
C
Wang Y
,
Spincemaille P
,
Liu Z
,
Dimov A
,
Deh K
,
Li J
,
Zhang Y
,
Yao Y
,
Gillen KM
,
Wilman AH
et al.
. 2017.
Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.
.
J Magn Reson Imaging. 46(4):951-971.
D
Fox RJ
,
Coffey CS
,
Cudkowicz ME
,
Gleason T
,
Goodman A
,
Klawiter EC
,
Matsuda K
,
McGovern M
,
Conwit R
,
Naismith R
et al.
. 2016.
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
.
Contemp Clin Trials. 50:166-77.
I
Eskreis-Winkler S
,
Zhou D
,
Liu T
,
Gupta A
,
Gauthier SA
,
Wang Y
,
Spincemaille P
. 2017.
On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping.
.
Magn Reson Imaging. 35:154-159.
M
Dayan M
,
RĂșa SMHurtado
,
Monohan E
,
Fujimoto K
,
Pandya S
,
LoCastro EM
,
Vartanian T
,
Nguyen TD
,
Raj A
,
Gauthier SA
. 2017.
MRI Analysis of White Matter Myelin Water Content in Multiple Sclerosis: A Novel Approach Applied to Finding Correlates of Cortical Thinning.
.
Front Neurosci. 11:284.
N
Kappos L
,
Havrdova E
,
Giovannoni G
,
Khatri BO
,
Gauthier SA
,
Greenberg SJ
,
You X
,
Wang P
,
Giannattasio G
. 2017.
No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study.
.
Mult Scler. 23(13):1736-1747.
O
Rumah KR
,
Vartanian T
,
Fischetti VA
. 2017.
Oral Multiple Sclerosis Drugs Inhibit the In vitro Growth of Epsilon Toxin Producing Gut Bacterium, Clostridium perfringens.
.
Front Cell Infect Microbiol. 7:11.
R
Kaunzner UW
,
Kang Y
,
Monohan E
,
Kothari PJ
,
Nealon N
,
Perumal J
,
Vartanian T
,
Kuceyeski A
,
Vallabhajosula S
,
P Mozley D
et al.
. 2017.
Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.
.
Mult Scler Relat Disord. 15:27-33.
S
Kaunzner UW
,
Kumar G
,
Askin G
,
Gauthier SA
,
Nealon N
,
Vartanian T
,
Perumal J
. 2016.
A study of patients with aggressive multiple sclerosis at disease onset.
.
Neuropsychiatr Dis Treat. 12:1907-12.